TY  - GEN
AU  - Shimazawa,Rumiko
AU  - Ikeda,Masayuki
TI  - Regulatory perspectives on next-generation sequencing and complementary diagnostics in Japan
SN  - 1744-8352
PY  - 2021///1004
KW  - B7-H1 Antigen
KW  - antagonists & inhibitors
KW  - Carcinoma, Non-Small-Cell Lung
KW  - drug therapy
KW  - DNA Mutational Analysis
KW  - economics
KW  - Databases, Nucleic Acid
KW  - Device Approval
KW  - legislation & jurisprudence
KW  - Direct-To-Consumer Screening and Testing
KW  - Drug Resistance, Microbial
KW  - genetics
KW  - Equipment and Supplies
KW  - classification
KW  - Genetic Diseases, Inborn
KW  - Government Agencies
KW  - organization & administration
KW  - Health Services Needs and Demand
KW  - High-Throughput Nucleotide Sequencing
KW  - Humans
KW  - Immune Checkpoint Inhibitors
KW  - pharmacology
KW  - Japan
KW  - Lung Neoplasms
KW  - Medical Device Legislation
KW  - Molecular Diagnostic Techniques
KW  - Molecular Targeted Therapy
KW  - Mutation
KW  - National Health Programs
KW  - Neoplasm Proteins
KW  - Neoplasms
KW  - Precision Medicine
KW  - methods
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1080/14737159.2020.1728256
ER  -